Tag: Therapy & Procedures: Misc.
COVID-19 Convalescent Plasma No Benefit for Most Patients
No association with clinical outcomes for typical patients; heterogeneity of treatment effect sizes seen across baseline characteristics
Trials Show Promise for Intravitreal Faricimab in Retinal Disease
Faricimab noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration, diabetic macular edema
Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19
For asymptomatic SARS-CoV-2-positive individuals living with infected household contact, combo cuts incidence of symptomatic COVID-19
Adverse Birth Outcomes Tied to ART Unlikely Due to Treatment
Difference in frequency of adverse outcomes small and statistically insignificant for siblings conceived naturally, through ART
Hyaluronic Acid Injection Use Increased for Knee Osteoarthritis in Seniors
Significant increase in utilization and associated costs seen among physicians' assistants and nurse practitioners
One-Third of Clinicians Still Offer Endometrial Scratching
Endometrial scratching still might be offered for psychological reasons
Racial Disparities in Treatment Account for 20 Percent of Differences in BP Control
Additionally, racial differences in visit attendance account for a smaller portion of differences in BP control
PRP Injections Do Not Ease Pain in Knee Osteoarthritis
No difference seen in change in median tibial cartilage volume at 12 months for platelet-rich plasma versus saline placebo injections
Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia
Only 14 percent of hospitals that referred patients with acute promyelocytic leukemia had ATRA readily available
AAV Gene Transfer Feasible for the Treatment of Hemophilia A
In a phase 1-2 trial, 16 of 18 men had sustained expression of factor VIII after gene transfer with adeno-associated viral vector (SPK-8011)
